Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1826 (118th)

PSA Screening for HIM Act

referredUnited States· United States Congress· EN

Introduced

28 March 2023

Last action

7 April 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Bucshon, Larry [R-IN-8], Rep. Clarke, Yvette D. [D-NY-9], Rep. Dunn, Neal P. [R-FL-2], Rep. Carter, Troy A. [D-LA-2], Rep. Cohen, Steve [D-TN-9], Rep. Thompson, Bennie G. [D-MS-2], Rep. Johnson, Bill [R-OH-6], Rep. Pettersen, Brittany [D-CO-7], Rep. Sherrill, Mikie [D-NJ-11], Rep. Mfume, Kweisi [D-MD-7], Rep. Rutherford, John H. [R-FL-5], Rep. Payne, Donald M., Jr. [D-NJ-10], David Scott, Rep. Bishop, Sanford D. [D-GA-2], Sen. Kim, Andy [D-NJ], Rep. Ivey, Glenn [D-MD-4], Rep. Gooden, Lance [R-TX-5], Rep. Pingree, Chellie [D-ME-1], Rep. Wilson, Frederica S. [D-FL-24], Rep. Davis, Donald G. [D-NC-1], Rep. Tlaib, Rashida [D-MI-12], Rep. Raskin, Jamie [D-MD-8], Sen. Blunt Rochester, Lisa [D-DE], Rep. Ross, Deborah K. [D-NC-2], Rep. Connolly, Gerald E. [D-VA-11], Rep. Frost, Maxwell [D-FL-10], Rep. Nickel, Wiley [D-NC-13], Yadira Caraveo, Rep. Matsui, Doris O. [D-CA-7], Rep. Gomez, Jimmy [D-CA-34], Rep. McCollum, Betty [D-MN-4], Rep. Lawler, Michael [R-NY-17], Rep. Wild, Susan [D-PA-7], Rep. Davids, Sharice [D-KS-3], Rep. Cherfilus-McCormick, Sheila [D-FL-20], Rep. Lee, Barbara [D-CA-12], Rep. Morelle, Joseph D. [D-NY-25], Rep. Watson Coleman, Bonnie [D-NJ-12], Rep. Keating, William R. [D-MA-9], Rep. Wilson, Joe [R-SC-2], Rep. Tonko, Paul [D-NY-20], Rep. Meng, Grace [D-NY-6], Rep. Valadao, David G. [R-CA-22], Rep. Schneider, Bradley Scott [D-IL-10], Rep. Blumenauer, Earl [D-OR-3], Rep. Trone, David J. [D-MD-6], Rep. Jackson, Jeff [D-NC-14], Colin Allred

Subjects

Healthcare

Source updated

13 November 2024

Healthcare

Summary

Prostate-Specific Antigen Screening for High-risk Insured Men Act or the PSA Screening for HIM Act This bill requires private health insurance plans to cover preventive prostate cancer screenings that are not already covered under the recommendations of the U.S. Preventive Services Task Force for men with a family history of prostate cancer, without imposing any cost-sharing requirement.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 March 2023

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 28 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 7 April 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 March 2023

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 March 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 March 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 94 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.